
For resistant breast cancers, two drugs may be better than one
For resistant breast cancers, two drugs may be better than one Cancer cells are even smarter than scientists previously believed, according to new CU Boulder research. When these cells are confronted with potent new drugs called CDK2 inhibitors, which are…